Premium
RITUXIMAB MAINTENANCE AFTER NORDIC PROTOCOL ( R‐MAXICHOP/HD‐ARAC/ASCT ) SIGNIFICANTLY PROLONGS SURVIVAL IN YOUNG MANTLE CELL LYMPHOMA PATIENTS
Author(s) -
Klener P.,
Salek D.,
Mocikova H.,
Blahovcova P.,
Pytlik R.,
Janikova A.,
Prochazka V.,
Campr V.,
Boudova L.,
Jaksa R.,
Kodet R.,
Trneny M.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_70
Subject(s) - medicine , mantle cell lymphoma , rituximab , cytarabine , gastroenterology , lymphoma , surgery , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom